FMSFRESENIUS MEDICAL CARE CORP

NYSE www.freseniusmedicalcare.com


$ 20.22 $ -0.54 (-2.6 %)    

Thursday, 25-Apr-2024 15:59:55 EDT
QQQ $ 429.60 $ 8.58 (2.04 %)
DIA $ 380.88 $ -3.56 (-0.93 %)
SPY $ 507.81 $ 5.55 (1.11 %)
TLT $ 87.78 $ -0.61 (-0.69 %)
GLD $ 215.92 $ 1.27 (0.59 %)
$ 20.76
$ 20.33
$ 0.00 x 0
$ 0.00 x 0
$ 20.19 - $ 20.33
$ 16.37 - $ 27.72
396,251
na
0
$ 0.68
nm
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-are-dialysis-provider-stocks-trading-higher-on-tuesday

Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with sema...

 why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

 nio-reports-upbeat-earnings-joins-dave-v2x-riskified-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

 dialysis-player-fresenius-medicals-q4-sales-hold-steady-details

Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.

 earnings-scheduled-for-february-20-2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

 fresenius-medical-care-q4-adjusted-epads-047-beats-032-estimate-sales-537b-beat-535b-estimate

Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $...

 the-fda-has-granted-510k-clearance-to-fresenius-medical-cares-5008x-hemodialysis-system-the-clearance-allows-the-start-of-clinical-evaluations-and-user-studies-in-us-with-a-planned-broad-commercial-launch-in-2025

https://www.freseniusmedicalcare.com/en/news/industry-leading-dialysis-therapy-us

 fresenius-medical-care-executes-on-its-strategic-portfolio-optimization-program-and-announces-key-transactions

Divestments in 2023 are important milestones of the Company's execution against its Portfolio Optimization which are part o...

 fresenius-majority-owned-group-mabxience-has-licensing-agreement-with-intas-pharmaceuticals-for-autoimmune-disease-drug-etanercept

 Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical company, has announced today a strategic exclusive licensin...

 fresenius-medical-care-hit-by-major-data-breach-half-a-million-patients-potentially-affected

Fresenius Medical Care (NYSE: FMS) said in a 

 hsbc-upgrades-fresenius-medical-care-to-hold

HSBC analyst Sezgi Oezener upgrades Fresenius Medical Care (NYSE:FMS) from Reduce to Hold.

 fresenius-medical-care--expects-net-positive-impact-on-operating-income-guidance-basis-of-approx-eur-175m-in-q4

As a consequence of the settlement agreement, Fresenius Medical Care today raises its earnings outlook. The company now expects...

 fresenius-medical-care-enters-into-favorable-settlement-agreement-with-us-government-expects-both-revenue-and-operating-income-to-be-positively-impacted

Fresenius Medical Care had filed a complaint against the United States in 2019. This complaint sought to recover monies owed to...

Core News & Articles

- Reuters

 truist-securities-maintains-hold-on-fresenius-medical-care-lowers-price-target-to-24

Truist Securities analyst David Macdonald maintains Fresenius Medical Care (NYSE:FMS) with a Hold and lowers the price targe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION